Stay updated on Dupilumab in AFRS Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in AFRS Clinical Trial page.

Latest updates to the Dupilumab in AFRS Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details and navigation with an access-denied screen. This indicates a server-side access issue or restriction that prevents users from viewing the trial record.SummaryDifference19%

- Check24 days agoChange DetectedNo changes were recorded for the page, so the content remains as published.SummaryDifference0.0%

- Check31 days agoChange DetectedStudy alias updated from LIBERTY-AFRS-AI to AFRS (AIMS). The 2026 entries reflect a new listing and rebranding of the trial.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the page. It appears to be a minor metadata update rather than substantive changes to study details or content.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated to v3.6.5. EFC16724 Plain Language Results Summary, Sanofi, Helpful Links Provided by, and Revision: v3.6.4 were removed.SummaryDifference0.1%

- Check67 days agoChange DetectedA new Publications item was added, listing the author names and a PubMed citation for a related article. It notes that publications are automatically filled from PubMed.SummaryDifference0.2%

Stay in the know with updates to Dupilumab in AFRS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in AFRS Clinical Trial page.